The clinical trial about the coronary plaque change by Rosuvastatin in ACS patients
Not Applicable
- Conditions
- Acute Coronary Syndrome
- Registration Number
- JPRN-UMIN000004302
- Lead Sponsor
- Tokushima University Hospital department of cardiology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
cardiac shock allergy to Rosuvastation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Observation of coronary plaque change in 2 weeks after taking the Rosuvastatin
- Secondary Outcome Measures
Name Time Method